Antidepressant effects of buprenorphine (Q72535102)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6126640 AND SRC:MED&resulttype=core&format=json

27 October 2019

title

Antidepressant effects of buprenorphine (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6126640 AND SRC:MED&resulttype=core&format=json

27 October 2019

author name string

H. M. Emrich

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:6126640

10 August 2023

P. Vogt

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:6126640

10 August 2023

A. Herz

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:6126640

10 August 2023

W. Kissling

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:6126640

10 August 2023

language of work or name

English

0 references

publication date

1 September 1982

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6126640 AND SRC:MED&resulttype=core&format=json

27 October 2019

25 September 1982

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6126640

full work available at URL

10 August 2023

https://api.elsevier.com/content/article/PII:S0140673682907279?httpAccept=text/xml

1 reference

10.1016/S0140-6736(82)90727-9

DOI

https://api.crossref.org/works/10.1016/S0140-6736(82)90727-9

https://api.elsevier.com/content/article/PII:S0140673682907279?httpAccept=text/plain

10 August 2023

1 reference

10.1016/S0140-6736(82)90727-9

DOI

https://api.crossref.org/works/10.1016/S0140-6736(82)90727-9

10 August 2023

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6126640 AND SRC:MED&resulttype=core&format=json

27 October 2019

volume

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6126640 AND SRC:MED&resulttype=core&format=json

27 October 2019

issue

8300

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6126640 AND SRC:MED&resulttype=core&format=json

27 October 2019

page(s)

709

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6126640 AND SRC:MED&resulttype=core&format=json

Clinical antidepressant activity of cyclazocine-a narcotic antagonist

27 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(82)90727-9

7 January 2021

Beta-endorphin--induced changes in schizophrenic and depressed patients

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(82)90727-9

7 January 2021

beta-Endorphin. Intravenous infusion causes behavioral change in psychiatric inpatients

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(82)90727-9

7 January 2021

The opiate antagonist naloxone modifies the effects of electroconvulsive shock (ECS) on respiration, blood pressure and heart rate

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(82)90727-9

7 January 2021

β-Endorphin-Like Immunoreactivity in Cerebrospinal Fluid and Plasma of Patients with Schizophrenia and Other Neuropsychiatric Disorders

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(82)90727-9

7 January 2021

Buprenorphine in postoperative pain: results in 7500 patients

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(82)90727-9

7 January 2021

Indication of an Antipsychotic Action of the Opiate Antagonist Naloxone

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(82)90727-9

7 January 2021

10.1016/S0140-6736(82)90727-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6126640 AND SRC:MED&resulttype=core&format=json

27 October 2019

1 reference